Ax-003/Arimidex (Anastrozole) in the Adjuvant Therapy of Early Breast Cancer - No Study Results Posted

Home Search Study Topics Glossary

Ax-003/Arimidex (Anastrozole) in the Adjuvant Therapy of Early Breast Cancer

This study has been completed.

Study NCT00638391 Information provided by AstraZeneca

First Received: March 13, 2008 Last Updated: March 19, 2008 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Study Completion Date:	March 2007
Estimated Primary Completion Date:	No date given